Lancet Summit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lancet summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lancet Summit Today - Breaking & Trending Today

Men may have a more severe SSc-ILD disease course than women

Men with SSc-ILD may experience worse outcomes than women, which could be explained by sex differences in biomarker profiles. ....

United States , Kerri Johannson , Los Angeles , Anna Maria Hoffmann , Vold Oslo University Hospital , University Of Calgary , Elizabeth Volkmann University Of California , Lancet Rheumatology , Amanda Grant Orser , Lancet Summit , Maria Hoffmann Vold , Oslo University Hospital ,

Sex Differences Seen in Inflammatory Arthritis Healthcare Use

Women’s higher risk of conditions such as osteoarthritis and pain and fatigue may help to explain why overall healthcare resource use was higher in female patients with inflammatory arthritis. ....

United States , Scott Zashin , Sanjana Tarannum , Women Health , Women College Research Institute , Enid Walker Graduate Student Award For Research , Lancet Summit , College Research Institute , Related Differences Emerge , Seek Out Care , Enid Walker Graduate Student Award , Rheumatoid Arthritis , Oint Inflammation , Osteoarthritis Oa , Steoarthritis Generalized , A Osteoarthritis , Egenerative Joint Disease Djd , Rthritis Degenerative , Eneralized Osteoarthritis , Degenerative Arthritis , Pain Management , Pain Management , Ankylosing Spondylitis Bechterews Disease , Psoriatic Arthritis , Ankylosing Spondylitis ,

Hormones' Impact Described in Transgender Rheumatology Patients

Gender-affirming hormone therapy does not need to be a strict contraindication in transgender patients with rheumatic disease, an author of a new case series and systematic review said. ....

Johns Hopkins University , United States , Vagishwari Murugesan , Kristen Mathias , University Of Toronto , University Of Southern California Medical Center , Lancet Summit , Los Angeles County , Southern California Medical Center , Could Pave Way , Larger Studies , Systemic Lupus Erythematosus , Social Issues , Rheumatic Disease , Rheumatoid Arthritis , Systemic Sclerosis , Diffuse Scleroderma , Endocrine Therapy , Hormone Therapy , Autoimmune Disease , Physician Patient Decision Making , Patient Counseling , Rovider Patient Communication ,

Severe COVID-19–Related Outcomes Found Worse in Men With RA

A retrospective electronic health record study of patients with rheumatoid arthritis and COVID-19 showed that men had more baseline comorbidities and increased risk of COVID-19 outcomes than females. ....

New York , United States , City Of , United Kingdom , Xiaofeng Zhou , Janet Pope , University Of Western Ontario , Lancet Summit , African American , Middle East , Bolsters Evidence , Western Ontario , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Uman Coronavirus Oc43 , Cov Oc43 , Uman Coronavirus 229e , Cov 229e , Acute Respiratory Distress Syndrome , Cute Respiratory Distress Syndrome Ards , Adult Respiratory Distress Syndrome , Severe Acute Respiratory Syndrome Sars , Evere Acute Respiratory Syndrome , Covid 19 Vaccine ,

GeNeuro Announces the Completion of Its ProTEct-MS Study and Confirms the March Timeline for Top-line Results, Provides a Business Update and Cash Position as of December 31, 2021

Completion of ProTEct-MS Phase 2 Clinical trial of temelimab in multiple sclerosis (MS) with Karolinska Institutet Academic Specialist Center of Stockholm Top line results confirmed for March ....

United States , Karolinska Institutet , Arthur Rouill , Miguel Payr , David Leppert , Louis Victor Delouvrier Mathilde Bohin , Swiss Federal Office Of Public Health , Academic Specialist Center , Us National Institutes Of Health , Karolinska Institutet Academic Specialist Center , National Institute Of Neurological Disorders , American Neurological Association , Swiss Federal Office , Public Health , Euronext Paris , Chief Medical Officer , North America , Western Europe , Lateral Disease , National Institute , Neurological Disorders , Chief Financial Officer , Multiple Sclerosis , Lateral Sclerosis , Lancet Summit , Presymptomatic Prevention ,